Clinical trial POSITIVE
A study evaluating the pregnancy outcomes and safety of interrupting endocrine therapy for young women with endocrine responsive breast cancer who desire pregnancy
| Cancers | |
|---|---|
| Organ | Breast |
| Trial status | Trial closed for recruitment |
| Investigator | |
| Trial type |
Prospective observational study
|
| Phase | Trial phase 3 |
| Academic trial | Non |
| Sponsor | IBCSG |
| BECT Identifier | B322201524608 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT02308085 |
| Inclusion criteria | ER+/HER2-. Adjuvant. End of hormonotherapy for pregnancy |
| Last update |